NLRP3 inflammasome: Its regulation and involvement in atherosclerosis
Z Hoseini, F Sepahvand, B Rashidi… - Journal of cellular …, 2018 - Wiley Online Library
Inflammasomes are intracellular complexes involved in the innate immunity that convert
proIL‐1β and proIL‐18 to mature forms and initiate pyroptosis via cleaving procaspase‐1 …
proIL‐1β and proIL‐18 to mature forms and initiate pyroptosis via cleaving procaspase‐1 …
Inflammation as a cardiovascular risk factor
JT Willerson, PM Ridker - Circulation, 2004 - ahajournals.org
Inflammation occurs in the vasculature as a response to injury, lipid peroxidation, and
perhaps infection. Various risk factors, including hypertension, diabetes, and smoking, are …
perhaps infection. Various risk factors, including hypertension, diabetes, and smoking, are …
Itaconate suppresses atherosclerosis by activating a Nrf2-dependent antiinflammatory response in macrophages in mice
Itaconate has emerged as a critical immunoregulatory metabolite. Here, we examined the
therapeutic potential of itaconate in atherosclerosis. We found that both itaconate and the …
therapeutic potential of itaconate in atherosclerosis. We found that both itaconate and the …
The cardiovascular effect of the uremic solute indole-3 acetic acid
L Dou, M Sallée, C Cerini, S Poitevin… - Journal of the …, 2015 - journals.lww.com
In CKD, uremic solutes may induce endothelial dysfunction, inflammation, and oxidative
stress, leading to increased cardiovascular risk. We investigated whether the uremic solute …
stress, leading to increased cardiovascular risk. We investigated whether the uremic solute …
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
KS Michelsen, MH Wong, PK Shah, W Zhang… - Proceedings of the …, 2004 - pnas.org
Toll-like receptors (TLRs) and the downstream adaptor molecule myeloid differentiation
factor 88 (MyD88) play an essential role in the innate immune responses. Here, we …
factor 88 (MyD88) play an essential role in the innate immune responses. Here, we …
Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association
EM Antman, JS Bennett, A Daugherty, C Furberg… - Circulation, 2007 - ahajournals.org
Clinical trial data have prompted questions about the degree to which patients and their
physicians should consider an increased risk of cardiovascular or cerebrovascular events …
physicians should consider an increased risk of cardiovascular or cerebrovascular events …
Chemistry and biology of vitamin E
C Schneider - Molecular nutrition & food research, 2005 - Wiley Online Library
Our understanding of the role of vitamin E in human nutrition, health, and disease has
broadened and changed over the past two decades. Viewed initially as nature's most potent …
broadened and changed over the past two decades. Viewed initially as nature's most potent …
The macrophage foam cell as a target for therapeutic intervention
AC Li, CK Glass - Nature medicine, 2002 - nature.com
Specialized functions of macrophages have evolved to protect the body from infection.
However, the same mechanisms that enable phagocytosis of pathogens and activation of …
However, the same mechanisms that enable phagocytosis of pathogens and activation of …
Nuclear factor κB signaling in atherogenesis
MPJ De Winther, E Kanters, G Kraal… - … , and vascular biology, 2005 - ahajournals.org
Atherosclerosis is an inflammatory disease, characterized by the accumulation of
macrophage-derived foam cells in the vessel wall and accompanied by the production of a …
macrophage-derived foam cells in the vessel wall and accompanied by the production of a …
Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis
JH Dwyer, H Allayee, KM Dwyer, J Fan… - … England Journal of …, 2004 - Mass Medical Soc
Background Leukotrienes are inflammatory mediators generated from arachidonic acid
(polyunsaturated n–6 fatty acid) by the enzyme 5-lipoxygenase. Since atherosclerosis …
(polyunsaturated n–6 fatty acid) by the enzyme 5-lipoxygenase. Since atherosclerosis …